Multi-drug-resistant tuberculosis (MDR-TB): Current situation in South Africa
South African Family Practice
Field | Value | |
Title | Multi-drug-resistant tuberculosis (MDR-TB): Current situation in South Africa | |
Creator | Ogunbanjo, Gboyega A | |
Description | Multi-drug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection which is resistant to treatment with at least two of the most powerful first-line anti-TB drugs, namely isoniazid and rifampicin. Globally, MDR-TB caused an estimated 480 000 new TB cases and 250 000 deaths in 2015 and accounted for 3.3% of all new TB cases worldwide.1 MDR-TB, or rifampicin-resistant TB, causes 3.9% of new TB cases and 21% of previously treated TB cases, and most MDR-TB cases occur in South America, southern Africa, India, China, and the former Soviet Union.1 | |
Publisher | AOSIS | |
Date | 2017-05-11 | |
Identifier | 10.4102/safp.v59i2.4679 | |
Source | South African Family Practice; Vol 59, No 2 (2017): March/April; 5 2078-6204 2078-6190 | |
Language | eng | |
Relation |
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
https://safpj.co.za/index.php/safpj/article/view/4679/5539
|
|
ADVERTISEMENT